PROT has recently announced it's intention to list on the OTCBB. I have always taken a more serious look at companies graduating from the pink sheets (now otcmarkets). Proteonomix is a biotechnology company focused on developing therapeutics based upon the use of human cells and their derivatives. Proteonomix has facilities at a number of academic institutions. Its subsidiary, Proteoderm has developed a line of anti-aging cosmetics. The company has experienced some price appreciation since December of 2009. Additionally, there have been two insider purchases at $1.5
This information was collected from otcMarkets.
This is not a solicitation to buy or sell a security. Additionally, we have not been compensated for the production of this material. Please consult a registered investment advisor prior to making any investment decision.